Polytrap Pharma Private Limited
About Polytrap Pharma Private Limited
Data last updated:
Polytrap Pharma Private Limited is a private limited company based in Indore, Madhya Pradesh, India. It operates in the dyes and pigments segment of the chemicals and materials sector. It was incorporated on 01 July 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U24290MP2021PTC056502. Its GSTIN is 23AAMCP0967G1ZB (Madhya Pradesh).
The company has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Deepti Shrivastava and Jyoti Shrivastava.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 122 Prikanko Colony N. No. 80793, Indore, Madhya Pradesh, India – 452009.
As per the financials filed for FY 2024, the company reported a revenue of ₹2.02 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹25.56 Lakh (net margin 12.6%) and EBITDA of ₹36.81 Lakh (EBITDA margin 18.2%).
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address122 Prikanko Colony N. No. 80793, Indore, Madhya Pradesh, India – 452009
- IndustryChemicals and Materials, Dyes & Pigments, Colorants
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Polytrap Pharma Private Limited
The main business activity of Polytrap Pharma is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Polytrap Pharma Private Limited FY 2025 filings available
Polytrap Pharma Private Limited reported revenue of ₹2.02 Cr (up 61% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Polytrap Pharma Private Limited
Revenue rose 61% in the latest year. EBITDA rose 189% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Polytrap Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• |
| EBITDA | ₹36.81 Lakh | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• |
| Net Profit (PAT) | ₹25.56 Lakh | •••• | •••• |
| Balance Sheet | |||
| Share Capital | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• |
Financial Ratios of Polytrap Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 18.2% | •••• | •••• |
| Net Profit Margin | 12.6% | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• |
| Liquidity and Debt | |||
| Current Ratio | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• |
| Efficiency and Growth | |||
| Asset Turnover | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Polytrap Pharma are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Polytrap Pharma Private Limited
Polytrap Pharma Private Limited is compared with the companies closest to it by revenue in the Chemicals industry (Dyes and Pigments, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Vianex Pharmaceuticals Private Limited | ₹2.03 Cr (FY 2024) | •••• | •••• | 50.0% | •••• | Neyyattinkara, Kerala, India |
| Unopolis Healthcare Private Limited | ₹2.03 Cr (FY 2024) | •••• | •••• | 234.0% | •••• | Burdwan, West Bengal, India |
| Toya Resins P Ltd | ₹2.03 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Ambattur Madras, Tamil Nadu, India |
| Aqmed Laboratories Private Limited | ₹2.03 Cr (FY 2025) | •••• | •••• | 195.0% | •••• | Petlad, Gujarat, India |
| SH Healthcare Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | 39.0% | •••• | Gurgaon, Haryana, India |
| Polytrap Pharma Private Limited this company | ₹2.02 Cr (FY 2024) | •••• | •••• | 61.0% | •••• | Indore, Madhya Pradesh, India |
| Drug for Life India Private Limited | ₹2.02 Cr (FY 2024) | •••• | •••• | 10.0% | •••• | Chandigarh, India |
| Planet Herbs Lifesciences Private Limited | ₹2.02 Cr (FY 2024) | •••• | •••• | -12.0% | •••• | New Delhi, Delhi, India |
| Kind Health and Hygiene Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | -35.0% | •••• | Junnar, Maharashtra, India |
| Vivenza International Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | 91.0% | •••• | Mumbai, Maharashtra, India |
| Clementia Pharmaceuticals Private Limited | ₹2.02 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Thane, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Polytrap Pharma by revenue in the Chemicals industry (Dyes and Pigments, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Polytrap Pharma Private Limited
Polytrap Pharma Private Limited is audited by R.D. JOSHI & CO. for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| R.D. JOSHI & CO. | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Polytrap Pharma Private Limited
Polytrap Pharma has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deepti Shrivastava | Director | 01 Jul 2021 | 5 Years 3 Months | Current |
| Jyoti Shrivastava | Director | 19 Nov 2021 | 4 Years 10 Months | Current |
Ownership and Shareholding of Polytrap Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Polytrap Pharma Private Limited
Polytrap Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Polytrap Pharma Private Limited
Polytrap Pharma Private Limited has a workforce of 0 employees as of Mar 26, 2024.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Polytrap Pharma Private Limited
Polytrap Pharma Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Adity Shrivastava ceased to be Director on 29 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Polytrap Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Polytrap Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Polytrap Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Polytrap Pharma Private Limited
Polytrap Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AAMCP0967G1ZB | Madhya Pradesh | Active | 07 Jun 2023 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Polytrap Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Polytrap Pharma Private Limited
Polytrap Pharma is an active private limited company based in Indore, Madhya Pradesh, India. The company works in dyes and pigments, within the chemicals and materials industry. It was incorporated on 01 July 2021 (5+ years old) and is registered under CIN U24290MP2021PTC056502.
Polytrap Pharma reported revenue of ₹2.02 Cr for FY 2024 (up 61% YoY).
Polytrap Pharma has 2 current directors:
- Deepti Shrivastava - Director
- Jyoti Shrivastava - Director
Polytrap Pharma reported a net profit of ₹25.56 Lakh (net margin 12.6%) and EBITDA of ₹36.81 Lakh (EBITDA margin 18.2%) for FY 2024, as per its filed financial statements.
The GSTIN of Polytrap Pharma is 23AAMCP0967G1ZB, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Polytrap Pharma is U24290MP2021PTC056502. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Polytrap Pharma was incorporated on 01 July 2021, making it 5+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Polytrap Pharma by revenue are Vianex Pharmaceuticals Private Limited, Unopolis Healthcare Private Limited, Toya Resins P Ltd, Aqmed Laboratories Private Limited, SH Healthcare Private Limited and 5 more, all in the Chemicals industry (Dyes and Pigments, Formulations).
Adity Shrivastava ceased to be Director on 29 Nov 2021. Jyoti Shrivastava was appointed as Director on 19 Nov 2021. Adity Shrivastava was appointed as Director on 01 Jul 2021. Polytrap Pharma has 4 board changes on record in total.
The registered office of Polytrap Pharma is at 122 Prikanko Colony N. No. 80793, Indore, Madhya Pradesh, India – 452009.
Polytrap Pharma has an authorised share capital of ₹50 Lakh and a paid-up capital of ₹1 Lakh.